Arca
Skip to content

TLR9: Toll-like receptor 9

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Key component of innate and adaptive immunity.

  • Drugs that act on it: 9
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
HydroxychloroquineApprovedToll-like receptor 9 antagonistAntagonist—
1018 iss—Toll-like receptor 9 agonistAgonist—
Agatolimod—Toll-like receptor 9 agonistAgonist—
Bazlitoran—Toll-like receptor 9 antagonistAntagonist—
Cobitolimod—Toll-like receptor 9 agonistAgonist—
EMD-1201081—Toll-like receptor 9 agonistAgonist—
Lefitolimod—Toll-like receptor 9 agonistAgonist—
Tilsotolimod—Toll-like receptor 9 agonistAgonist—
Tilsotolimod sodium—Toll-like receptor 9 agonistAgonist—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Malaria
0.58
COVID-19
0.44
Cutaneous lupus erythematosus
0.43
Non-small cell lung carcinoma
0.38
Pulmonary sarcoidosis
0.33

Drugs and mechanisms are from ChEMBL CHEMBL5804 (CC BY-SA 3.0). Gene name, function (UniProt Q9NR96, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.